Navigation Links
InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
Date:2/7/2008

sting supply agreement with Boehringer Ingelheim Austria for the commercial and clinical supply of Actimmune.

Fourth Quarter and Recent Business Highlights

-- Pirfenidone: On November 26, InterMune announced that it had entered

into agreements with Marnac, Inc. and with co-licensor KDL GmbH that

will eliminate future royalty and milestone payment obligations for

pirfenidone related to the 2002 license agreement. The principal terms

of the new agreements were:

-- InterMune made total acquisition payments to the companies of $13.7

million. Of this total, a $7.5 million expense recorded in the

third quarter of 2007 relating to the 2002 license agreement was

applied to the acquisition payments for the new agreements. The

$6.2 million balance of the acquisition payments for the new

agreements was recorded in the fourth quarter of 2007.

-- Contingent acquisition payments associated with the new agreements

of up to an additional $53.5 million would be made by InterMune

only if positive Phase 3 data and registration in the United States

and European Union are achieved.

-- In addition, InterMune acquired exclusive worldwide rights from

Marnac to certain additional intellectual property for pirfenidone

that was not licensed under the 2002 licensing agreement, including

patents relating to the TNF-alpha activities of the compound.

-- ITMN-191: On January 7, 2008, InterMune reported the progress of its

Phase 1b multiple-ascending-dose (MAD) clinical trial evaluating

ITMN-191 (R7227) as monotherapy in patients with chronic hepatitis C

virus (HCV) infection. InterMune reported that:

-- It had completed the first two dosage cohorts in the study, with

total daily doses of up to 300mg, and that
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
7. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
8. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
9. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
10. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Marianjoy Rehabilitation Hospital has ... hand impairments by acquiring the Armeo®Spring arm and ... site. , Secured through grant support of a ... option for patients with upper extremity weakness or ... of just four Illinois providers offering treatment with ...
(Date:5/1/2015)... , May 1, 2015 /CNW/ - Softchoice, a leading North American ... is the proud recipient of two Cisco® Partner Summit Country ... of the Year and Security Partner of the Year for ... taking place this week in Montreal . ... but two Cisco partner awards at this year,s conference," said ...
(Date:5/1/2015)... SILVER SPRING, Md. and RESEARCH TRIANGLE ... Corporation (NASDAQ: UTHR ) announced today that Roger ... Therapeutics, will provide an overview and update on the company,s ... Care Conference in Boston, Massachusetts . ... 2015, at 3:30 PM Eastern Time, and can be accessed ...
(Date:4/30/2015)... 30, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... that it has commenced an underwritten public offering of ... the underwriters a 30-day option to purchase up to ... stock offered in the public offering. The offering is ... assurance as to whether or when the offering may ...
Breaking Biology Technology:Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2Softchoice recognized with two Country Awards at Cisco Partner Summit 2015 2BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3
... Brownstein, Art Director at CONNEXION Healthcare (CXHC), ... by the Healthcare Businesswomen,s Association (HBA). HBA ... sectors of the healthcare industry, including pharmaceutical, ... market research. Nominated by HBA,s corporate members, ...
... Calif., Feb. 18 Amgen Inc. (Nasdaq: ... Drug Administration (FDA) has accepted Amgen,s submission and filed ... RANK Ligand inhibitor. The indications for which Amgen ... postmenopausal osteoporosis (PMO) in women and treatment and prevention ...
... Speed up the Peer Review Process!COLUMBIA, S.C., ... Bulletin Board: CLXS), a leading developer of ... today that the American Association for Cancer ... Finder and Journal Dashboard applications for the ...
Cached Biology Technology:Jennifer Brownstein, of CONNEXION Healthcare, Honored as 'Rising Star' by Healthcare Businesswomen's Association 2FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 2FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 3FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 4FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 5FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 6American Association for Cancer Research (AACR) Deploys Collexis' Reviewer Finder and Journal Dashboard Applications 2American Association for Cancer Research (AACR) Deploys Collexis' Reviewer Finder and Journal Dashboard Applications 3
(Date:4/9/2015)... JOSE, Calif. , April 9, 2015 ... human interface solutions, announced today that it will report ... on Thursday, April 23, 2015, after the close of ... for analysts and investors at 2:00 p.m. PT (5:00 ...   To participate on the live call, ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:3/31/2015)... YORK , March 31, 2015   Guidepoint ... the launch of the Post-Surgical Pain Management TRACKER, part ... products tracking usage trends in the medical device and ... access to data including treatment volumes, market share, and ... the pain associated with joint surgery. The ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... a negative view of climate engineering, the deliberate large-scale ... to a new study. The results are from ... (New Zealand) who have undertaken the first systematic large-scale ... The work is published in Nature Climate ...
... announced today the purchase of an Irys ™ System ... genome assembly of Aegilops tauschii, one of three progenitors ... led by Dr. Jan Dvorak , will use the Irys ... orientation of all genes and transposable elements of the A. ...
... of Nottingham have discovered a key difference in the biological ... bacterial pathogens. The study, published in the journal ... the University,s School of Life Sciences, centred on STAT1, a ... role in regulating genes in the body. STAT-1 responds ...
Cached Biology News:Climate engineering -- what do the public think? 2UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 2UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 3UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 4UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 5Research uncovers key difference between our bodies' fight against viruses and bacteria 2